{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"huntington-disease-like","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Huntington&#x27;s disease-like (HDL) is a group of related neurological conditions. As the name suggests, HDLs resembles Huntington&#x27;s disease. HDLs and Huntington&#x27;s disease are both characterized by uncontrolled movements, emotional problems, and loss of thinking ability. In both conditions these signs and symptoms worsen over time. HDLs occurs in people with the characteristic features of Huntington&#x27;s disease who do not have a variant (also called mutation) in the gene typically associated with that disorder. Researchers have described four HDLs that are designated Huntington&#x27;s disease-like 1 (HDL1) through Huntington&#x27;s disease-like 4 (HDL4). Sometimes, HDL4 is also known as spinocerebellar ataxia type 17 (SCA17). HDL1, HDL2, and HDL4 usually begin in early to mid-adulthood, although they can start earlier or later. The first signs and symptoms of these conditions often include irritability, emotional problems, small involuntary movements (dyskinesia), poor coordination, and trouble learning new information or making decisions. Many people with an HDL develop involuntary jerking or twitching movements known as chorea. Over time, these abnormal movements worsen. Affected individuals may develop slowness of movement (bradykinesia), speaking (dysarthria), and swallowing (dysphagia). People with these disorders also experience changes in personality and a decline in thinking and reasoning abilities (dementia). Individuals with an HDL syndrome can live for 10 to 20 years after signs and symptoms begin, though this can vary between the types of HDL syndromes. HDL3 begins much earlier in life than the other HDLs (usually around age 3 or 4). Affected children experience a decline in thinking ability, difficulties with movement and speech, and seizures. Because HDL3 has some different signs and symptoms and a different pattern of inheritance, researchers are unsure whether it belongs in the same category as the other HDLs.","mondoId":"MONDO:0015548","node":{"canonicalSlug":"huntington-disease-like","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Huntington disease-like syndrome","originalSourceId":"ORPHA:158266","paragraphs":["Huntington's disease-like (HDL) is a group of related neurological conditions. As the name suggests, HDLs resembles Huntington's disease. HDLs and Huntington's disease are both characterized by uncontrolled movements, emotional problems, and loss of thinking ability. In both conditions these signs and symptoms worsen over time. HDLs occurs in people with the characteristic features of Huntington's disease who do not have a variant (also called mutation) in the gene typically associated with that disorder. Researchers have described four HDLs that are designated Huntington's disease-like 1 (HDL1) through Huntington's disease-like 4 (HDL4). Sometimes, HDL4 is also known as spinocerebellar ataxia type 17 (SCA17). HDL1, HDL2, and HDL4 usually begin in early to mid-adulthood, although they can start earlier or later. The first signs and symptoms of these conditions often include irritability, emotional problems, small involuntary movements (dyskinesia), poor coordination, and trouble learning new information or making decisions. Many people with an HDL develop involuntary jerking or twitching movements known as chorea. Over time, these abnormal movements worsen. Affected individuals may develop slowness of movement (bradykinesia), speaking (dysarthria), and swallowing (dysphagia). People with these disorders also experience changes in personality and a decline in thinking and reasoning abilities (dementia). Individuals with an HDL syndrome can live for 10 to 20 years after signs and symptoms begin, though this can vary between the types of HDL syndromes. HDL3 begins much earlier in life than the other HDLs (usually around age 3 or 4). Affected children experience a decline in thinking ability, difficulties with movement and speech, and seizures. Because HDL3 has some different signs and symptoms and a different pattern of inheritance, researchers are unsure whether it belongs in the same category as the other HDLs."],"rawAttribution":"ORPHA:158266","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:42:58Z","upstream":"ORPHA:158266","url":"https://rarediseases.info.nih.gov/diseases/20029"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"Huntington disease and related disorders","mondoId":"MONDO:0000167","slug":null},{"kind":"parent","label":"hereditary dementia","mondoId":"MONDO:0015547","slug":"hereditary-dementia"},{"kind":"child","label":"Machado-Joseph disease","mondoId":"MONDO:0007182","slug":"spinocerebellar-ataxia-type-3"},{"kind":"child","label":"dentatorubral-pallidoluysian atrophy","mondoId":"MONDO:0007435","slug":"dentatorubral-pallidoluysian-atrophy"},{"kind":"child","label":"spinocerebellar ataxia type 1","mondoId":"MONDO:0008119","slug":"spinocerebellar-ataxia-type-1"},{"kind":"child","label":"spinocerebellar ataxia type 2","mondoId":"MONDO:0008458","slug":"spinocerebellar-ataxia-type-2"},{"kind":"child","label":"Huntington disease-like 3","mondoId":"MONDO:0011487","slug":"huntington-disease-like-3"},{"kind":"child","label":"neuroferritinopathy","mondoId":"MONDO:0011638","slug":"neuroferritinopathy"},{"kind":"child","label":"spinocerebellar ataxia type 17","mondoId":"MONDO:0011781","slug":"spinocerebellar-ataxia-type-17"},{"kind":"child","label":"neuroacanthocytosis","mondoId":"MONDO:0016987","slug":"neuroacanthocytosis"},{"kind":"child","label":"Huntington disease-like syndrome due to C9ORF72 expansions","mondoId":"MONDO:0018425","slug":"huntington-disease-like-syndrome-due-to-c9orf72-expansions"},{"kind":"child","label":"childhood-onset benign chorea with striatal involvement","mondoId":"MONDO:0044332","slug":"childhood-onset-benign-chorea-with-striatal-involvement"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published","editorialReview":{"reviewedAt":"2026-10-26","decision":"corrected","reason":"Bradykinesia means slowness of movement, not all walking problems.","sources":["https://www.ninds.nih.gov/health-information/disorders/parkinsons-disease"],"originalNarrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Huntington disease-like syndrome","originalSourceId":"ORPHA:158266","paragraphs":["Huntington's disease-like (HDL) is a group of related neurological conditions. As the name suggests, HDLs resembles Huntington's disease. HDLs and Huntington's disease are both characterized by uncontrolled movements, emotional problems, and loss of thinking ability. In both conditions these signs and symptoms worsen over time. HDLs occurs in people with the characteristic features of Huntington's disease who do not have a variant (also called mutation) in the gene typically associated with that disorder. Researchers have described four HDLs that are designated Huntington's disease-like 1 (HDL1) through Huntington's disease-like 4 (HDL4). Sometimes, HDL4 is also known as spinocerebellar ataxia type 17 (SCA17). HDL1, HDL2, and HDL4 usually begin in early to mid-adulthood, although they can start earlier or later. The first signs and symptoms of these conditions often include irritability, emotional problems, small involuntary movements (dyskinesia), poor coordination, and trouble learning new information or making decisions. Many people with an HDL develop involuntary jerking or twitching movements known as chorea. Over time, these abnormal movements worsen. Affected individuals may develop problems with walking (bradykinesia), speaking (dysarthria), and swallowing (dysphagia). People with these disorders also experience changes in personality and a decline in thinking and reasoning abilities (dementia). Individuals with an HDL syndrome can live for 10 to 20 years after signs and symptoms begin, though this can vary between the types of HDL syndromes. HDL3 begins much earlier in life than the other HDLs (usually around age 3 or 4). Affected children experience a decline in thinking ability, difficulties with movement and speech, and seizures. Because HDL3 has some different signs and symptoms and a different pattern of inheritance, researchers are unsure whether it belongs in the same category as the other HDLs."],"rawAttribution":"ORPHA:158266","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:42:58Z","upstream":"ORPHA:158266","url":"https://rarediseases.info.nih.gov/diseases/20029"},"claimHolds":[]}},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/20029\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>ORPHA:158266</dd></dl></details><p class=\"section-source\">Source clarification. <a href=\"https://www.ninds.nih.gov/health-information/disorders/parkinsons-disease\" rel=\"noreferrer\">1</a></p>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Huntington&#x27;s disease-like (HDL) is a group of related neurological conditions. As the name suggests, HDLs resembles Huntington&#x27;s disease. HDLs and Huntington&#x27;s disease are both characterized by uncontrolled movements, emotional problems, and loss of thinking ability. In both conditions these signs and symptoms worsen over time. HDLs occurs in people with the characteristic features of Huntington&#x27;s disease who do not have a variant (also called mutation) in the gene typically associated with that disorder. Researchers have described four HDLs that are designated Huntington&#x27;s disease-like 1 (HDL1) through Huntington&#x27;s disease-like 4 (HDL4). Sometimes, HDL4 is also known as spinocerebellar ataxia type 17 (SCA17). HDL1, HDL2, and HDL4 usually begin in early to mid-adulthood, although they can start earlier or later. The first signs and symptoms of these conditions often include irritability, emotional problems, small involuntary movements (dyskinesia), poor coordination, and trouble learning new information or making decisions. Many people with an HDL develop involuntary jerking or twitching movements known as chorea. Over time, these abnormal movements worsen. Affected individuals may develop slowness of movement (bradykinesia), speaking (dysarthria), and swallowing (dysphagia). People with these disorders also experience changes in personality and a decline in thinking and reasoning abilities (dementia). Individuals with an HDL syndrome can live for 10 to 20 years after signs and symptoms begin, though this can vary between the types of HDL syndromes. HDL3 begins much earlier in life than the other HDLs (usually around age 3 or 4). Affected children experience a decline in thinking ability, difficulties with movement and speech, and seizures. Because HDL3 has some different signs and symptoms and a different pattern of inheritance, researchers are unsure whether it belongs in the same category as the other HDLs.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/20029\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"huntington-disease-like","sourceDocuments":[{"name":"GARD: Huntington disease-like syndrome","reviewed":null,"source_release":"2026-10-25T03:42:58Z","url":"https://rarediseases.info.nih.gov/diseases/20029"}],"sourceNote":"","synonyms":["Huntington disease phenocopy syndrome"],"takeawayHtml":"","title":"Huntington disease-like syndrome"},"schemaVersion":1}
